Design, synthesis and preliminary evaluation of novel imperatorin derivatives as vasorelaxant agents. 2011

Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
College of Medicine, Xi'an Jiaotong University, No. 76, Yanta Weststreet, Xi'an, Shaanxi Province, 710061, PR China.

A series of novel imperatorin derivatives were synthesized from commercially available xanthotoxin. The in vitro pharmacological evaluation indicated that all of the compounds possessed potent vasodilatory activity. Among them, compounds (5b), (5d) and (5e) exhibited higher vasdilatory activity (with EC(50) values of 0.68 µM, 0.59 µM and 0.49 µM, respectively) than imperatorin (EC(50) = 1.12 µM). The program Volsurf was used to predict the derivatives' ADME-relevant descriptors. The results suggested that these novel compounds had a potential interest for the development of novel and potent vasorelaxant agents.

UI MeSH Term Description Entries
D008297 Male Males
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D011564 Furocoumarins Polycyclic compounds consisting of a furan ring fused with coumarin. They commonly occur in PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA. Furanocoumarin,Furanocoumarins,Furocoumarin,Psoralens,Angelicins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012984 Software Sequential operating programs and data which instruct the functioning of a digital computer. Computer Programs,Computer Software,Open Source Software,Software Engineering,Software Tools,Computer Applications Software,Computer Programs and Programming,Computer Software Applications,Application, Computer Software,Applications Software, Computer,Applications Softwares, Computer,Applications, Computer Software,Computer Applications Softwares,Computer Program,Computer Software Application,Engineering, Software,Open Source Softwares,Program, Computer,Programs, Computer,Software Application, Computer,Software Applications, Computer,Software Tool,Software, Computer,Software, Computer Applications,Software, Open Source,Softwares, Computer Applications,Softwares, Open Source,Source Software, Open,Source Softwares, Open,Tool, Software,Tools, Software
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
September 2010, European journal of medicinal chemistry,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
January 2013, Journal of Asian natural products research,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
July 2009, Archiv der Pharmazie,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
September 2015, Bioorganic & medicinal chemistry letters,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
November 2017, Molecules (Basel, Switzerland),
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
January 2015, European journal of medicinal chemistry,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
May 2012, Bioorganic & medicinal chemistry,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
July 2020, Advanced pharmaceutical bulletin,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
July 2003, Journal of medicinal chemistry,
Na Li, and Jianyu He, and Yingzhuan Zhan, and Nan Zhou, and Jie Zhang
July 2020, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!